Key Dates

Related Announcements

• September 16, 2023 - Notice of Technical Assistance Webinar and FAQs for NOT-HL-23-113 (NOSI). See Notice NOT-HL-23-111.
• August 9, 2023 - (EXPIRED) Notice of Special Interest (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established cohorts (R01 Clinical Trial Optional). See NOSI NOT-HL-23-102.
• August 25, 2023 - Notice of Special Interest (NOSI) : Promoting Implementation research to address HIV-associated comorbidities and risk factors within well-established longitudinal studies (R01 Clinical Trial Optional). See NOSI NOT-HL-23-113

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

This Notice is to inform the research community that NHLBI is expiring NOT-HL-23-102 Notice of Special Interest (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established cohorts (R01 Clinical Trial Optional) effective immediately. This NOSI is being reissued as NOT-HL-23-113 Notice of Special Interest (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established longitudinal studies (R01 Clinical Trial Optional) .

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact(s)

Mary Masterson PhD, MS
National Heart, Lung, and Blood Institute (NHLBI)
Center for Translation Research and Implementation Science (CTRIS)
Telephone: 301-827-6113
Email: [email protected]

Peer Review Contact(s)

Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).

Financial/Grants Management Contact(s)

Fatima Kamara
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-7916
Email: [email protected]